Drug intelligence / Profile preview

3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide

Development stage
Unknown
Modality
Small Molecules
01

Overview

3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide is a small molecule experimental compound with the molecular formula C16H14N2O3 and an average molecular weight of approximately 282.29 g/mol. It is known as an inhibitor of matrix metalloproteinase enzymes, specifically MMPs, which are involved in the breakdown of extracellular matrix components. This compound has been studied for its potential to inhibit MMP activity, which may be relevant in diseases involving tissue remodeling and degradation such as cancer metastasis or arthritis. However, it is not approved for clinical use and has no registered indications or marketed brand names. There are no known manufacturers or developers publicly listed for this compound.

Other names
3-(4'-Cyano-biphenyl-4-yloxy)-N-hydroxy-propionamide3-[4-(4-cyanophenyl)phenoxy]-N-hydroxypropanamideMMP-3 Inhibitor VIIMMP3 Inhibitor VIIMMP 3 Inhibitor VII
02

Targets

MMP3 (Matrix metalloproteinase-3)

Beyond the preview

Go deeper on 3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call